At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory ...

The Advisory Committee on Immunization Practices convened to make expanded vaccine recommendations amidst CDC leadership changes.

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

High rates of respiratory illnesses following a severe flu season prompted ChristianaCare to establish a telephone line to ...